PSTV – Plus Therapeutics Inc
PLUS THERAPEUTICS, Inc.PSTV
$1.17Name : PLUS THERAPEUTICS, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $6,898,706.00
EPSttm : -2.37
PLUS THERAPEUTICS, Inc.
$1.17
0.85%$0.01Float Short %
1.97
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
-0.04
EPS Last/This Y
2.18
EPS This/Next Y
-0.04
Price
1.19
Target Price
10.25
Analyst Recom
1
Performance Q
-18.18
Relative Volume
0.11
Beta
0.69
Ticker: PSTV
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | PSTV | 0.9663 | N/A | N/A | 0 |
| 2024-12-20 | PSTV | 1.09 | N/A | N/A | 0 |
| 2024-12-23 | PSTV | 1.07 | N/A | N/A | 0 |
| 2024-12-24 | PSTV | 1.08 | N/A | N/A | 0 |
| 2024-12-26 | PSTV | 1.1 | N/A | N/A | 0 |
| 2024-12-27 | PSTV | 1.155 | N/A | N/A | 0 |
| 2024-12-30 | PSTV | 1.15 | N/A | N/A | 0 |
| 2024-12-31 | PSTV | 1.14 | N/A | N/A | 0 |
| 2025-01-02 | PSTV | 1.175 | N/A | N/A | 0 |
| 2025-01-03 | PSTV | 1.2 | N/A | N/A | 0 |
| 2025-01-06 | PSTV | 1.255 | N/A | N/A | 0 |
| 2025-01-07 | PSTV | 1.2498 | N/A | N/A | 0 |
| 2025-01-08 | PSTV | 1.2 | N/A | N/A | 0 |
| 2025-01-09 | PSTV | 1.2 | N/A | N/A | 0 |
| 2025-01-10 | PSTV | 1.155 | N/A | N/A | 0 |
| 2025-01-13 | PSTV | 1.13 | N/A | N/A | 0 |
| 2025-01-14 | PSTV | 1.17 | N/A | N/A | 0 |
| 2025-01-15 | PSTV | 1.21 | N/A | N/A | 0 |
| 2025-01-16 | PSTV | 1.1901 | N/A | N/A | 0 |
| 2025-01-17 | PSTV | 1.1904 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | PSTV | 0.99 | 26.8 | - | -2.06 |
| 2024-12-20 | PSTV | 1.09 | 26.8 | - | -2.06 |
| 2024-12-23 | PSTV | 1.07 | 26.8 | - | -2.06 |
| 2024-12-24 | PSTV | 1.08 | 26.8 | - | -2.06 |
| 2024-12-26 | PSTV | 1.08 | 26.8 | - | -2.06 |
| 2024-12-27 | PSTV | 1.16 | 26.8 | - | -2.06 |
| 2024-12-30 | PSTV | 1.16 | 26.8 | - | -2.06 |
| 2024-12-31 | PSTV | 1.11 | 26.8 | - | -2.06 |
| 2025-01-02 | PSTV | 1.17 | 26.8 | - | -2.06 |
| 2025-01-03 | PSTV | 1.21 | 26.8 | - | -2.06 |
| 2025-01-06 | PSTV | 1.25 | 26.8 | - | -2.06 |
| 2025-01-07 | PSTV | 1.29 | 26.8 | - | -2.06 |
| 2025-01-08 | PSTV | 1.20 | 26.8 | - | -2.06 |
| 2025-01-09 | PSTV | 1.20 | 26.8 | - | -2.06 |
| 2025-01-10 | PSTV | 1.20 | 26.8 | - | -2.06 |
| 2025-01-13 | PSTV | 1.16 | 26.8 | - | -2.06 |
| 2025-01-14 | PSTV | 1.17 | 26.8 | - | -2.06 |
| 2025-01-15 | PSTV | 1.20 | 26.8 | - | -2.06 |
| 2025-01-16 | PSTV | 1.21 | 26.8 | - | -2.06 |
| 2025-01-17 | PSTV | 1.19 | 26.8 | - | -2.06 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | PSTV | 36.09 | -8.14 | 1.98 |
| 2024-12-20 | PSTV | 36.07 | -8.14 | 1.98 |
| 2024-12-23 | PSTV | 31.72 | -8.19 | 1.98 |
| 2024-12-24 | PSTV | 31.72 | -8.19 | 1.98 |
| 2024-12-26 | PSTV | 35.63 | -8.19 | 1.63 |
| 2024-12-27 | PSTV | 36.09 | -8.19 | 1.63 |
| 2024-12-30 | PSTV | 32.79 | -8.19 | 1.63 |
| 2024-12-31 | PSTV | 32.79 | -8.19 | 1.63 |
| 2025-01-02 | PSTV | 36.11 | -8.19 | 1.63 |
| 2025-01-03 | PSTV | 36.11 | -8.19 | 1.63 |
| 2025-01-06 | PSTV | 34.15 | -8.19 | 1.63 |
| 2025-01-07 | PSTV | 34.15 | -8.19 | 1.63 |
| 2025-01-08 | PSTV | 36.10 | -8.19 | 1.63 |
| 2025-01-09 | PSTV | 36.11 | -8.19 | 1.63 |
| 2025-01-10 | PSTV | 36.07 | -8.19 | 1.63 |
| 2025-01-13 | PSTV | 36.10 | -8.19 | 1.97 |
| 2025-01-14 | PSTV | 36.10 | -8.19 | 1.97 |
| 2025-01-15 | PSTV | 36.12 | -8.19 | 1.97 |
| 2025-01-16 | PSTV | 36.09 | -8.19 | 1.97 |
| 2025-01-17 | PSTV | 36.10 | -8.19 | 1.97 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.46
Avg. EPS Est. Current Quarter
-0.51
Avg. EPS Est. Next Quarter
-0.5
Insider Transactions
36.1
Institutional Transactions
-8.19
Beta
0.69
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
1
Fair Value
Quality Score
39
Growth Score
18
Sentiment Score
52
Actual DrawDown %
98.5
Max Drawdown 5-Year %
-98.2
Target Price
10.25
P/E
Forward P/E
PEG
P/S
1.21
P/B
P/Free Cash Flow
EPS
-2.24
Average EPS Est. Cur. Y
-2.06
EPS Next Y. (Est.)
-2.1
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-225.07
Relative Volume
0.11
Return on Equity vs Sector %
230
Return on Equity vs Industry %
242.5
EPS 1 7Days Diff
-0.1
EPS 1 30Days Diff
0.16
EBIT Estimation
PLUS THERAPEUTICS, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 20
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead radiotherapeutic drug candidate is rhenium (186Re) obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.
stock quote shares PSTV – Plus Therapeutics Inc Stock Price stock today
news today PSTV – Plus Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PSTV – Plus Therapeutics Inc yahoo finance google finance
stock history PSTV – Plus Therapeutics Inc invest stock market
stock prices PSTV premarket after hours
ticker PSTV fair value insiders trading